<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p44" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_44{left:36px;bottom:25px;letter-spacing:0.07px;word-spacing:0.01px;}
#t2_44{left:341px;bottom:30px;}
#t3_44{left:348px;bottom:25px;letter-spacing:0.11px;}
#t4_44{left:377px;bottom:30px;}
#t5_44{left:381px;bottom:25px;letter-spacing:0.07px;word-spacing:-0.1px;}
#t6_44{left:540px;bottom:30px;}
#t7_44{left:546px;bottom:25px;letter-spacing:0.07px;}
#t8_44{left:44px;bottom:77px;letter-spacing:0.1px;word-spacing:-0.05px;}
#t9_44{left:44px;bottom:63px;letter-spacing:0.1px;}
#ta_44{left:285px;bottom:860px;letter-spacing:-0.32px;word-spacing:0.06px;}
#tb_44{left:285px;bottom:827px;letter-spacing:-0.24px;}
#tc_44{left:996px;bottom:873px;letter-spacing:-0.1px;}
#td_44{left:1043px;bottom:853px;letter-spacing:-0.22px;word-spacing:0.13px;}
#te_44{left:1093px;bottom:833px;letter-spacing:-0.09px;}
#tf_44{left:1111px;bottom:28px;letter-spacing:0.1px;}
#tg_44{left:36px;bottom:198px;}
#th_44{left:42px;bottom:192px;letter-spacing:0.1px;word-spacing:-0.04px;}
#ti_44{left:325px;bottom:192px;}
#tj_44{left:36px;bottom:181px;}
#tk_44{left:45px;bottom:176px;letter-spacing:0.13px;}
#tl_44{left:260px;bottom:176px;}
#tm_44{left:36px;bottom:165px;}
#tn_44{left:42px;bottom:159px;letter-spacing:0.12px;}
#to_44{left:45px;bottom:142px;letter-spacing:0.1px;word-spacing:0.02px;}
#tp_44{left:45px;bottom:125px;letter-spacing:0.12px;}
#tq_44{left:45px;bottom:108px;letter-spacing:0.13px;}
#tr_44{left:129px;bottom:108px;}
#ts_44{left:36px;bottom:778px;letter-spacing:0.48px;}
#tt_44{left:36px;bottom:760px;letter-spacing:0.25px;}
#tu_44{left:933px;bottom:778px;letter-spacing:0.28px;word-spacing:-0.12px;}
#tv_44{left:187px;bottom:778px;letter-spacing:0.32px;word-spacing:-0.31px;}
#tw_44{left:1070px;bottom:539px;letter-spacing:-0.1px;}
#tx_44{left:1070px;bottom:521px;letter-spacing:-0.09px;}
#ty_44{left:1070px;bottom:502px;letter-spacing:-0.08px;}
#tz_44{left:1070px;bottom:441px;letter-spacing:-0.09px;}
#t10_44{left:1070px;bottom:423px;letter-spacing:-0.06px;}
#t11_44{left:1070px;bottom:404px;letter-spacing:-0.08px;}
#t12_44{left:1070px;bottom:386px;letter-spacing:-0.09px;}
#t13_44{left:1070px;bottom:368px;letter-spacing:-0.42px;}
#t14_44{left:36px;bottom:544px;letter-spacing:-0.09px;}
#t15_44{left:36px;bottom:526px;letter-spacing:-0.09px;}
#t16_44{left:36px;bottom:508px;letter-spacing:-0.07px;}
#t17_44{left:36px;bottom:489px;letter-spacing:-0.11px;}
#t18_44{left:36px;bottom:471px;letter-spacing:-0.1px;}
#t19_44{left:189px;bottom:693px;letter-spacing:-0.1px;}
#t1a_44{left:189px;bottom:675px;letter-spacing:-0.1px;}
#t1b_44{left:278px;bottom:682px;letter-spacing:-0.12px;}
#t1c_44{left:189px;bottom:615px;letter-spacing:-0.1px;}
#t1d_44{left:189px;bottom:554px;letter-spacing:-0.1px;}
#t1e_44{left:252px;bottom:562px;}
#t1f_44{left:189px;bottom:459px;letter-spacing:-0.1px;}
#t1g_44{left:189px;bottom:317px;letter-spacing:-0.09px;}
#t1h_44{left:189px;bottom:299px;letter-spacing:-0.11px;}
#t1i_44{left:304px;bottom:306px;letter-spacing:-0.15px;}
#t1j_44{left:189px;bottom:261px;letter-spacing:-0.1px;}
#t1k_44{left:189px;bottom:222px;letter-spacing:-0.08px;}
#t1l_44{left:671px;bottom:307px;letter-spacing:-0.11px;word-spacing:-0.62px;}
#t1m_44{left:859px;bottom:307px;letter-spacing:-0.24px;}
#t1n_44{left:371px;bottom:605px;letter-spacing:-0.1px;}
#t1o_44{left:371px;bottom:586px;letter-spacing:-0.09px;}
#t1p_44{left:371px;bottom:568px;letter-spacing:-0.08px;}
#t1q_44{left:371px;bottom:550px;letter-spacing:-0.09px;}
#t1r_44{left:371px;bottom:531px;letter-spacing:-0.09px;}
#t1s_44{left:371px;bottom:513px;letter-spacing:-0.08px;}
#t1t_44{left:371px;bottom:495px;letter-spacing:-0.1px;}
#t1u_44{left:553px;bottom:502px;}
#t1v_44{left:612px;bottom:617px;letter-spacing:-0.1px;}
#t1w_44{left:863px;bottom:625px;}
#t1x_44{left:612px;bottom:511px;letter-spacing:-0.1px;}
#t1y_44{left:612px;bottom:492px;letter-spacing:-0.09px;}
#t1z_44{left:612px;bottom:474px;letter-spacing:-0.09px;}
#t20_44{left:678px;bottom:482px;}
#t21_44{left:725px;bottom:574px;letter-spacing:-0.09px;}
#t22_44{left:725px;bottom:556px;letter-spacing:-0.1px;}
#t23_44{left:725px;bottom:537px;letter-spacing:-0.08px;}
#t24_44{left:725px;bottom:519px;letter-spacing:-0.11px;}
#t25_44{left:722px;bottom:456px;letter-spacing:-0.08px;}
#t26_44{left:722px;bottom:438px;letter-spacing:-0.09px;}
#t27_44{left:899px;bottom:565px;letter-spacing:-0.09px;}
#t28_44{left:899px;bottom:547px;letter-spacing:-0.1px;}
#t29_44{left:988px;bottom:554px;letter-spacing:-0.12px;}
#t2a_44{left:899px;bottom:528px;letter-spacing:-0.09px;}
#t2b_44{left:899px;bottom:486px;letter-spacing:-0.13px;}
#t2c_44{left:923px;bottom:494px;}
#t2d_44{left:899px;bottom:468px;letter-spacing:-0.06px;}
#t2e_44{left:899px;bottom:450px;letter-spacing:-0.09px;}
#t2f_44{left:899px;bottom:431px;letter-spacing:-0.09px;}
#t2g_44{left:899px;bottom:413px;letter-spacing:-0.1px;}
#t2h_44{left:988px;bottom:420px;letter-spacing:-0.12px;}
#t2i_44{left:562px;bottom:165px;}
#t2j_44{left:576px;bottom:159px;letter-spacing:0.12px;word-spacing:-0.03px;}
#t2k_44{left:1086px;bottom:159px;}
#t2l_44{left:562px;bottom:148px;}
#t2m_44{left:573px;bottom:142px;letter-spacing:0.1px;word-spacing:0.03px;}
#t2n_44{left:571px;bottom:125px;letter-spacing:0.08px;}
#t2o_44{left:593px;bottom:125px;letter-spacing:0.12px;word-spacing:-0.02px;}
#t2p_44{left:1135px;bottom:125px;}
#t2q_44{left:562px;bottom:114px;}
#t2r_44{left:573px;bottom:108px;letter-spacing:0.12px;}
#t2s_44{left:604px;bottom:108px;letter-spacing:0.12px;}
#t2t_44{left:682px;bottom:108px;letter-spacing:0.08px;word-spacing:0.05px;}
#t2u_44{left:432px;bottom:326px;letter-spacing:-0.09px;}
#t2v_44{left:432px;bottom:307px;letter-spacing:-0.09px;}
#t2w_44{left:432px;bottom:289px;letter-spacing:-0.09px;}
#t2x_44{left:432px;bottom:271px;letter-spacing:-0.1px;}
#t2y_44{left:934px;bottom:693px;letter-spacing:-0.09px;}
#t2z_44{left:934px;bottom:675px;letter-spacing:-0.09px;}
#t30_44{left:1000px;bottom:675px;letter-spacing:-0.25px;}
#t31_44{left:432px;bottom:695px;letter-spacing:-0.1px;}
#t32_44{left:432px;bottom:675px;letter-spacing:-0.09px;}
#t33_44{left:612px;bottom:380px;letter-spacing:-0.09px;}
#t34_44{left:612px;bottom:362px;letter-spacing:-0.09px;}
#t35_44{left:899px;bottom:368px;letter-spacing:-0.11px;}
#t36_44{left:999px;bottom:375px;}
#t37_44{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_44{font-size:9px;font-family:ArialMT_5tg;color:#000;}
.s1_44{font-size:5px;font-family:ArialMT_5tg;color:#000;}
.s2_44{font-size:12px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_44{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_44{font-size:17px;font-family:ArialMT_5tg;color:#0065A4;}
.s5_44{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s6_44{font-size:12px;font-family:ArialMT_5tg;color:#000;}
.s7_44{font-size:15px;font-family:ArialMT_5tg;color:#0065A4;}
.s8_44{font-size:15px;font-family:ArialMT_5tg;color:#000;}
.s9_44{font-size:17px;font-family:Arial-BoldMT_5te;color:#0065A4;}
.sa_44{font-size:17px;font-family:Arial-BoldMT_jz;color:#000;}
.sb_44{font-size:14px;font-family:Arial-BoldMT_5te;color:#000;}
.sc_44{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts44" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-BoldMT_jz;
	src: url("fonts/Arial-BoldMT_jz.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

</style>
<div id="pg44Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg44" style="-webkit-user-select: none;"><object width="1210" height="935" data="44/44.svg" type="image/svg+xml" id="pdf44" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_44" class="t s0_44">Version 4.2024, 5/1/2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_44" class="t s1_44">® </span>
<span id="t3_44" class="t s0_44">(NCCN </span>
<span id="t4_44" class="t s1_44">® </span>
<span id="t5_44" class="t s0_44">), All rights reserved. NCCN Guidelines </span>
<span id="t6_44" class="t s1_44">® </span>
<span id="t7_44" class="t s0_44">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_44" class="t s2_44">Note: All recommendations are category 2A unless otherwise indicated. </span>
<span id="t9_44" class="t s2_44">Clinical Trials: NCCN believes that the best management of any patient with cancer is in a clinical trial. Participation in clinical trials is especially encouraged. </span>
<span id="ta_44" class="t s3_44">NCCN Guidelines Version 4.2024 </span>
<span id="tb_44" class="t s3_44">Cancer of the Glottic Larynx </span>
<span id="tc_44" class="t s4_44">NCCN Guidelines Index </span>
<span id="td_44" class="t s4_44">Table of Contents </span>
<span id="te_44" class="t s4_44">Discussion </span>
<span id="tf_44" class="t s5_44">GLOT-4 </span>
<span id="tg_44" class="t s6_44">j </span>
<span id="th_44" class="t s7_44">Principles of Radiation Therapy (GLOT-A)</span><span id="ti_44" class="t s8_44">. </span>
<span id="tj_44" class="t s6_44">k </span>
<span id="tk_44" class="t s7_44">Principles of Surgery (SURG-A)</span><span id="tl_44" class="t s8_44">. </span>
<span id="tm_44" class="t s6_44">l </span>
<span id="tn_44" class="t s8_44">Adverse pathologic features: extranodal extension, positive margins, </span>
<span id="to_44" class="t s8_44">close margins, pT4 primary, pN2 or pN3 nodal disease, perineural </span>
<span id="tp_44" class="t s8_44">invasion, vascular invasion, lymphatic invasion, and subglottic extension </span>
<span id="tq_44" class="t s7_44">(Discussion)</span><span id="tr_44" class="t s8_44">. </span>
<span id="ts_44" class="t s5_44">CLINICAL </span>
<span id="tt_44" class="t s5_44">STAGING </span>
<span id="tu_44" class="t s5_44">ADJUVANT TREATMENT </span><span id="tv_44" class="t s5_44">TREATMENT OF PRIMARY AND NECK </span>
<span id="tw_44" class="t s5_44">Follow-up </span>
<span id="tx_44" class="t s9_44">(FOLL-A, 1 </span>
<span id="ty_44" class="t s9_44">of 2) </span>
<span id="tz_44" class="t s5_44">Recurrent </span>
<span id="t10_44" class="t s5_44">or </span>
<span id="t11_44" class="t s5_44">persistent </span>
<span id="t12_44" class="t s5_44">disease </span>
<span id="t13_44" class="t s9_44">(ADV-3) </span>
<span id="t14_44" class="t sa_44">T3 requiring </span>
<span id="t15_44" class="t s5_44">(amenable to) </span>
<span id="t16_44" class="t s5_44">total </span>
<span id="t17_44" class="t s5_44">laryngectomy </span>
<span id="t18_44" class="t s5_44">(N2–3) </span>
<span id="t19_44" class="t s5_44">Concurrent systemic </span>
<span id="t1a_44" class="t s5_44">therapy/RT </span>
<span id="t1b_44" class="t sb_44">j,m,n </span>
<span id="t1c_44" class="t s5_44">or </span>
<span id="t1d_44" class="t s5_44">Surgery </span>
<span id="t1e_44" class="t sb_44">k </span>
<span id="t1f_44" class="t s5_44">or </span>
<span id="t1g_44" class="t s5_44">Induction </span>
<span id="t1h_44" class="t s5_44">chemotherapy </span>
<span id="t1i_44" class="t sb_44">m,o </span>
<span id="t1j_44" class="t s5_44">or </span>
<span id="t1k_44" class="t s5_44">Clinical trials </span>
<span id="t1l_44" class="t s5_44">Response Assessment </span><span id="t1m_44" class="t s9_44">(GLOT-5) </span>
<span id="t1n_44" class="t s5_44">Laryngectomy with </span>
<span id="t1o_44" class="t s5_44">thyroidectomy as </span>
<span id="t1p_44" class="t s5_44">indicated, ipsilateral or </span>
<span id="t1q_44" class="t s5_44">bilateral neck dissection, </span>
<span id="t1r_44" class="t s5_44">and pretracheal and </span>
<span id="t1s_44" class="t s5_44">ipsilateral paratracheal </span>
<span id="t1t_44" class="t s5_44">lymph node dissection </span>
<span id="t1u_44" class="t sb_44">k </span>
<span id="t1v_44" class="t s5_44">No adverse pathologic features </span>
<span id="t1w_44" class="t sb_44">l </span>
<span id="t1x_44" class="t s5_44">Adverse </span>
<span id="t1y_44" class="t s5_44">pathologic </span>
<span id="t1z_44" class="t s5_44">features </span>
<span id="t20_44" class="t sb_44">l </span>
<span id="t21_44" class="t s5_44">Extranodal </span>
<span id="t22_44" class="t s5_44">extension and/ </span>
<span id="t23_44" class="t s5_44">or positive </span>
<span id="t24_44" class="t s5_44">margin </span>
<span id="t25_44" class="t s5_44">Other risk </span>
<span id="t26_44" class="t s5_44">features </span>
<span id="t27_44" class="t s5_44">Systemic </span>
<span id="t28_44" class="t s5_44">therapy/RT </span>
<span id="t29_44" class="t sb_44">j,m </span>
<span id="t2a_44" class="t s5_44">(category 1) </span>
<span id="t2b_44" class="t s5_44">RT </span>
<span id="t2c_44" class="t sb_44">j </span>
<span id="t2d_44" class="t s5_44">or </span>
<span id="t2e_44" class="t s5_44">Consider </span>
<span id="t2f_44" class="t s5_44">systemic </span>
<span id="t2g_44" class="t s5_44">therapy/RT </span>
<span id="t2h_44" class="t sb_44">j,m </span>
<span id="t2i_44" class="t s6_44">m </span>
<span id="t2j_44" class="t s7_44">Principles of Systemic Therapy for Non-Nasopharyngeal Cancers (SYST-A)</span><span id="t2k_44" class="t s8_44">. </span>
<span id="t2l_44" class="t s6_44">n </span>
<span id="t2m_44" class="t s8_44">When using concurrent systemic therapy/RT, the preferred agent is cisplatin (category </span>
<span id="t2n_44" class="t s8_44">1). </span><span id="t2o_44" class="t s7_44">See Principles of Systemic Therapy for Non-Nasopharyngeal Cancers (SYST-A)</span><span id="t2p_44" class="t s8_44">. </span>
<span id="t2q_44" class="t s6_44">o </span>
<span id="t2r_44" class="t s8_44">See </span><span id="t2s_44" class="t s7_44">Discussion </span><span id="t2t_44" class="t s8_44">on induction chemotherapy. </span>
<span id="t2u_44" class="t s5_44">CT (with contrast) </span>
<span id="t2v_44" class="t s5_44">or MRI (with and </span>
<span id="t2w_44" class="t s5_44">without contrast) of </span>
<span id="t2x_44" class="t s5_44">primary and neck </span>
<span id="t2y_44" class="t s5_44">Recurrent or persistent </span>
<span id="t2z_44" class="t s5_44">disease </span><span id="t30_44" class="t s9_44">(ADV-3) </span>
<span id="t31_44" class="t s9_44">Post Systemic Therapy/RT or RT </span>
<span id="t32_44" class="t s9_44">Neck Evaluation (FOLL-A, 2 of 2) </span>
<span id="t33_44" class="t s5_44">pN1 without other </span>
<span id="t34_44" class="t s5_44">risk features </span>
<span id="t35_44" class="t s5_44">Consider RT </span>
<span id="t36_44" class="t sb_44">j </span>
<span id="t37_44" class="t sc_44">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
